Scientists Develop First Injectable Treatment to Reverse Osteoarthritis

Osteoarthritis affects 240 million people worldwide with no cure, leaving patients with only pain management or expensive surgery as options. A new injectable therapy developed with $33.5 million in ARPA-H funding could reverse joint damage by harnessing the body's natural regenerative capabilities. This breakthrough represents a fundamental shift from treating symptoms to potentially curing the disease itself.